Leandro A. Avelar-Alves

Duesseldorf, NW 40225, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia.

Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia.

Journal: Journal of medicinal chemistry

Published: November 27, 2024

Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignancies.

Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignancies.

Journal: Experimental cell research

Published: January 23, 2024

Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites.

Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites.

Journal: Experimental parasitology

Published: December 14, 2023

Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities.

Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 28, 2022

Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies.

Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies.

Journal: Molecular cancer therapeutics

Published: March 24, 2022

Antiproliferation and Antiencystation Effect of Class II Histone Deacetylase Inhibitors on Acanthamoeba castellanii.

Antiproliferation and Antiencystation Effect of Class II Histone Deacetylase Inhibitors on Acanthamoeba castellanii.

Journal: ACS infectious diseases

Published: January 07, 2022

Designing HDAC-PROTACs: lessons learned so far.

Designing HDAC-PROTACs: lessons learned so far.

Journal: Future medicinal chemistry

Published: December 24, 2021

A short overview of resistance to approved histone deacetylase inhibitors.

A short overview of resistance to approved histone deacetylase inhibitors.

Journal: Future medicinal chemistry

Published: May 07, 2021

Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors.

Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors.

Journal: European journal of medicinal chemistry

Published: October 01, 2020

Structure-based design of selective histone deacetylase 6 zinc binding groups.

Structure-based design of selective histone deacetylase 6 zinc binding groups.

Journal: Journal of biomolecular structure & dynamics

Published: August 07, 2019

Novel reverse thia-analogs of fosmidomycin: Synthesis and antiplasmodial activity.

Novel reverse thia-analogs of fosmidomycin: Synthesis and antiplasmodial activity.

Journal: European journal of medicinal chemistry

Published: June 07, 2019

Recent advances in class IIa histone deacetylases research.

Recent advances in class IIa histone deacetylases research.

Journal: Bioorganic & medicinal chemistry

Published: March 29, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026